Becton Dickinson (BD) and ICU Medical Lead the Global Needleless Connector Market to 2030 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Needleless Connector Market Size, Share & Trends Analysis 2024-2030 MedCore Includes: Hospital NLCs and Non-Hospital NLCs” report has been added to ResearchAndMarkets.com’s offering.


The global needleless connector market showcased impressive expansion in 2023, reaching a total value of $1.33 billion. This figure represents a substantial 5.8% increase from the previous year’s market valuation of $1.26 billion.

Future projections for the needleless connector market indicate a stable growth trajectory, with a compound annual growth rate (CAGR) of 4.5%, culminating in an estimated value of $1.80 billion. Remarkably, the global needleless connector market is currently led by two key players, Becton Dickinson (BD) and ICU Medical.

Market Overview

Strong Growth: The global needleless connector market experienced robust growth in 2023, reaching a total valuation of $1.33 billion, marking a 5.8% increase compared to the previous year.

Market Leaders: Becton Dickinson (BD) and ICU Medical have emerged as dominant forces in the global needleless connector market.

Comprehensive Research: This comprehensive medical market research involved an extensive analysis of more than 15 intravenous set companies spanning seven continents. Employing a rigorous methodology, the research examined market sizes, unit sales, company market shares, and generated precise forecasts. The report provides a comprehensive overview of both hospital and non-hospital needleless connectors within the global intravenous sets market.

Market Insights

Emerging Markets: The forecasted period anticipates emerging markets benefiting from a gradual shift towards mechanical valve devices. While concerns have been raised regarding specific configurations of mechanical valve needleless connectors (NLCs), a significant number of these devices have proven their capability to enhance overall patient outcomes. This shift towards mechanical valve NLCs is expected to positively impact the overall market’s value in the coming years.

Global Market Leaders

Becton Dickinson (BD): In 2023, Becton Dickinson (BD) solidified its position as the global leader in the Needleless Connector (NLC) market. The company’s dual role as an infusion pump manufacturer further strengthens its position, allowing for the bundling of NLCs with its devices. This strategy enhances brand recognition and its ability to manufacture and market various disposable products in substantial quantities at competitive prices.

ICU Medical: ICU Medical secured the second position in the global NLC market in 2023. The company’s ClaveT connector, featuring innovative design that seamlessly integrates the external blunt cannula into the split septum structure, ensures compatibility with any standard male Luer connector.

Market Segmentation

Needleless Connector Market – Segmented By: Care Setting (Hospital, Non-Hospital)

Leading Companies

Becton Dickinson

ICU Medical

B. Braun

Vygon

Baxter

Terumo

Rymed Technologies

CODAN

Nexus Medical

The global needleless connector market is poised for sustained growth, with Becton Dickinson (BD) and ICU Medical at the forefront of market leadership. Emerging markets are expected to benefit from a shift towards mechanical valve devices, and the industry will continue to see innovation and competition among players.

For more information about this report visit https://www.researchandmarkets.com/r/czqtif

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.